Maybe. Bug count alone will not tell you. The more useful question is what evidence says the software is actually ready to release.
One catastrophic defect is more important than 150 spelling mistakes. Ten minor defects in a low-use admin screen may matter less than one intermittent failure in payment. Yet teams still put a giant ‘OPEN DEFECTS: 87’ number on a slide and act as if mathematics has made the decision for them.
If the defect list is making everyone nervous, an independent view can separate ‘ugly but shippable’ from ‘absolutely do not press the button’.
Look at consequence, exposure and recovery
For each serious defect, ask how often it could happen, who it affects, what the consequence is, whether there is a safe workaround and whether you can detect and recover from it quickly.
Then ask whether the defect is telling you something bigger. Five unrelated minor issues are probably five minor issues. Five failures around saving data may mean the underlying area is not stable and the visible defects are simply the bits you happened to catch.
Do not let severity labels do the thinking
A ‘medium’ label does not make a defect medium. Teams regularly negotiate defect language until it fits the release they already want. ‘Customer cannot complete payment’ becomes ‘intermittent payment user experience issue’ and everybody feels better without the software changing at all.
Delaying also has a cost. That matters. A sensible decision compares the risk of releasing with the risk and cost of waiting. The answer is not automatically ‘testers found bugs, therefore stop’. It is also not ‘the date is in the plan, therefore go’.
Look for clusters, not just individual tickets
Defects often tell a story when you stop reading them one at a time. Repeated failures around permissions may point to a flawed access model. Repeated data fixes may point to a fragile transaction design. A pile of apparently separate UI bugs after every release may tell you your regression coverage or front-end architecture is weak.
That matters to the delay decision because fixing the visible ticket may not remove the underlying instability. If the same area keeps producing new serious defects every time you touch it, another short test cycle after one fix may not be enough evidence.
On the other hand, do not let a large backlog of cosmetic or accepted low-impact defects become a convenient reason to postpone forever. The aim is not a pristine Jira board. The aim is a release whose remaining risk is understood and tolerable.
If you need somebody outside the delivery pressure to review the defect position and tell you what actually matters, speak to us. We can look at the defects, coverage, workarounds and release context and give you an independent recommendation without first asking what colour the steering committee would prefer.